TheraRadar
← Back
Data updated: Mar 29, 2026

GLAND PHARMA LTD

CardiovascularOphthalmologyInfectious Disease
Generics

GLAND PHARMA LTD is a generic drug manufacturer focused on Cardiovascular, Ophthalmology, Infectious Disease.

2004
Since
11
Drugs
-
Trials
121
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

KETOROLAC TROMETHAMINE 2026-01-22
Labeling
HALOPERIDOL 2025-12-18
ONDANSETRON HYDROCHLORIDE 2025-11-18
Labeling
ONDANSETRON HYDROCHLORIDE 2025-11-17
Labeling
ONDANSETRON HYDROCHLORIDE 2025-11-17
Labeling
ONDANSETRON HYDROCHLORIDE 2025-10-23
Labeling
ONDANSETRON HYDROCHLORIDE 2025-10-23
Labeling
LABETALOL HYDROCHLORIDE 2025-10-02
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 33%
2 drugs
Ophthalmology 17%
1 drugs
Infectious Disease 17%
1 drugs
Respiratory 17%
1 drugs
Dermatology 17%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Dermatology, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Cardiovascular
Novartis big-pharma
Cardiovascular, Ophthalmology, Respiratory
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Ophthalmology, Infectious Disease, Cardiovascular